Mohawk Industries (MHK) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Dec, 2025Executive summary
Q4 2024 net sales were $2.6 billion, up 1% year-over-year, with adjusted EPS of $1.95, matching the prior year despite a challenging environment.
Full-year 2024 net sales totaled $10.8 billion, down 2.7% year-over-year, with adjusted EPS of $9.70, up 6%; free cash flow reached $680 million.
Margins benefited from restructuring, productivity improvements, and lower interest expense, but were offset by unfavorable pricing, mix, and higher input costs.
Market conditions remained soft due to high interest rates, low housing turnover, and reduced remodeling activity globally; commercial outperformed residential but is slowing.
Prior year included $878 million in non-cash impairment charges, resulting in a net loss for 2023.
Financial highlights
Q4 adjusted operating income was $160 million (6.1% margin); adjusted EBITDA was $310 million, down 5.4% year-over-year.
Q4 adjusted gross margin was 24.4%; adjusted SG&A as a percent of sales was 18.4%.
Net debt at year-end was $1.6 billion; leverage ratio improved to 1.1x.
Q4 free cash flow was $236 million; full-year free cash flow $680 million.
Full-year adjusted operating margin was 7.6%.
Outlook and guidance
Q1 2025 adjusted EPS expected between $1.34 and $1.44, including a $0.35 per share impact from Flooring North America system issues.
Ongoing market softness anticipated in Q1 due to high interest rates and weak housing; normal seasonal improvement expected in Q2.
Annualized restructuring savings of $285 million expected by 2026; $100 million incremental savings targeted for 2025.
CapEx planned at $520 million in 2025, focused on product innovation, sales growth, and cost reduction.
Short-term outlook anticipates continued pricing pressure, higher input costs, and FX headwinds; restructuring and productivity actions to benefit results.
Latest events from Mohawk Industries
- Q4 2025 net sales rose 2.4% to $2.7B; 2026 outlook expects improved sales and earnings.MHK
Q4 202527 Feb 2026 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 202418 Jan 2026 - Q1 2025 sales fell 5.7% to $2.53B; adjusted EPS $1.52; tariffs add $50M in costs.MHK
Q1 202525 Dec 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing1 Dec 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 202524 Oct 2025 - Flat Q2 2025 sales, margin pressure, and a $500M buyback amid ongoing cost and tariff risks.MHK
Q2 202525 Jul 2025